PBE:NYE-Invesco Dynamic Biotechnology & Genome ETF (USD)

ETF | Health |

Last Closing

USD 67.88

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-11 )

ETFs Containing PBE

WBIR 0.00 % 1.25 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.03% 71% C- 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.03% 71% C- 84% B
Trailing 12 Months  
Capital Gain 4.43% 70% C- 53% F
Dividend Return 0.05% 13% F N/A F
Total Return 4.48% 71% C- 42% F
Trailing 5 Years  
Capital Gain 22.57% 43% F 63% D
Dividend Return 0.14% 11% F N/A F
Total Return 22.71% 43% F 52% F
Average Annual (5 Year Horizon)  
Capital Gain 5.69% 62% D 53% F
Dividend Return 5.71% 57% F 46% F
Total Return 0.01% 11% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 20.87% 48% F 53% F
Risk Adjusted Return 27.35% 52% F 41% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.